ANNIE SINGH: Open Payments
NPI 1609466051 · NEWARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,711 in 137 payments from 18 companies in 2025. Trend: 2023 $4,071 · 2024 $5,236 · 2025 $2,711
Food & beverage: $2,521Education: $190
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $505 |
| Incyte Corporation | 15 | $289 |
| LEO Pharma Inc. | 19 | $268 |
| Janssen Biotech, Inc. | 10 | $258 |
| UCB, Inc. | 13 | $205 |
| Lilly USA, LLC | 13 | $200 |
| Regeneron Healthcare Solutions, Inc. | 8 | $193 |
| Arcutis Biotherapeutics, Inc. | 12 | $190 |
| GENZYME CORPORATION | 7 | $169 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
Products named: DUPIXENT, OPZELURA, ADBRY, TREMFYA, SKYRIZI, Bimzelx, TALTZ, Zoryve.
Industry payments across CA — which companies pay providers there.
